Society of Surgical Oncology: Position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007

Annals of Surgical Oncology

Volumn 14, Issue 9, 2007, Pages 2425-2427

  Giuliano, Armando E ^a   Boolbol, Susan ^b   Degnim, Amy ^c   Kuerer, Henry ^d   Leitch, A Marilyn ^e   Morrow, Monica ^f  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; GENE MUTATION; HEALTH INSURANCE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; MASTECTOMY; MEDICAL SOCIETY; PRACTICE GUIDELINE; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION; SHORT SURVEY; TREATMENT INDICATION; TUMOR BIOPSY;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASTECTOMY; MEDICAL ONCOLOGY; PATIENT SELECTION; PRIMARY PREVENTION; RISK FACTORS;

EID: 34548564513     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9447-z     Document Type: Short Survey

References (0)